World's first generic to leading GnRH analogue with controlled release
Xbrane is pioneering high demand biosimilars.
OUTPERFORMING INDUSTRY STANDARDS BY DEVELOPING BIOSIMILARS WITH NEXT GENERATION TECHNOLOGY
Enabling access to critical medication for life critical diseases
Investors
Latest News
-
Xbrane Biopharma AB: Spherotide erhåller marknadsgodkännande i Iran
Read more >> -
Xbrane Biopharma AB: Spherotide granted Market Authorization in Iran
Read more >> -
Xbrane Biopharma AB: Kompletterande information om Xbrane Biopharma ABs (publ) långsiktiga aktiesparprogram för anställda
Read more >> -
Xbrane Biopharma AB: Complementary information on Xbrane Biopharma AB's (publ) long-term share savings program for employees
Read more >> -
Xbrane Biopharma AB (publ) lanserar långsiktigt aktiesparprogram för anställda
Read more >>
Events
-
09 Jan 2017
J.P. Morgan 35th Annual Healthcare Conference, January 9-12
Read more >>
X
